Answers are grounded in this paper and cite their sources.
Background: Ga-68 labelled Prostate specific membrane antigen-Positron emission tomography (PSMA-PET) is widely used in staging of intermediate and high-risk prostate cancer or restaging after biochemical recurrence.Despite the term "prostate specific", incidental uptake with Ga-68 PSMA-PET in benign and non-prostatic malignancy has been reported.Case Report: Here we present two cases of carcinoma prostate with PSMA-PET avid lesions in thyroid, requiring further evaluations due to its non-specificity and on evaluation found to be a synchronous double malignancy of prostate and carcinoma thyroid.Conclusion: PSMA-PET, though has high sensitivity and specificity in staging for prostate cancer, can be taken up by multiple other malignancies and non-malignant conditions.If clinical picture warrants, additional confirmatory investigations are required, might change the staging and the treatment.
No takes yet. Share an insight, caveat, or question.
Sasikala et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: